Sy Co., Ltd. (KOSDAQ:109610)
2,320.00
+30.00 (1.31%)
At close: Jun 17, 2026
Sy Co., Ltd. Revenue
Sy Co., Ltd. had revenue of 126.30B KRW in the quarter ending March 31, 2026, with 8.60% growth. This brings the company's revenue in the last twelve months to 511.55B, down -5.15% year-over-year. In the year 2025, Sy Co., Ltd. had annual revenue of 501.55B, down -10.60%.
Revenue (ttm)
511.55B
Revenue Growth
-5.15%
P/S Ratio
0.22
Revenue / Employee
1.55B
Employees
329
Market Cap
110.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 501.55B | -59.46B | -10.60% |
| Dec 31, 2024 | 561.01B | 7.34B | 1.33% |
| Dec 31, 2023 | 553.67B | 16.47B | 3.07% |
| Dec 31, 2022 | 537.20B | 113.10B | 26.67% |
| Dec 31, 2021 | 424.10B | 114.03B | 36.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sambo Motors | 1.70T |
| DongKoo Bio & Pharma | 242.08B |
| YTN Co.,Ltd. | 150.70B |
| HYUNDAI BIOLAND | 135.04B |
| D&C Media | 84.97B |
| LS THiRA-UTECH | 60.80B |
| Cell Biotech | 56.49B |
| IMT Co., Ltd. | 39.53B |